Qube Research & Technologies LTD Supernus Pharmaceuticals, Inc. Transaction History

Qube Research & Technologies LTD

$93.8 Billion
Q2 2025

A detailed history of Qube Research & Technologies LTD transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 229,710 shares of SUPN stock, worth $9.47 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

229,710

Previous 98,078 134.21%

Holding current value

$9.47 Million

Previous $3.21 Million 125.4%

% of portfolio

0.01%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$30.29 - $33.43 $3.99 Million - $4.4 Million	131,632 Added 134.21%	229,710 $7.24 Million
Q1 2025 May 15, 2025	BUY	$31.17 - $40.0 $1.03 Million - $1.32 Million	32,968 Added 50.63%	98,078 $3.21 Million
Q4 2024 Feb 14, 2025	SELL	$31.89 - $37.83 $1.14 Million - $1.36 Million	-35,854 Reduced 35.51%	65,110 $2.35 Million
Q3 2024 Nov 14, 2024	SELL	$25.77 - $35.16 $1.53 Million - $2.08 Million	-59,208 Reduced 36.97%	100,964 $3.15 Million
Q2 2024 Aug 14, 2024	BUY	$25.99 - $33.85 $3.91 Million - $5.1 Million	150,569 Added 1567.94%	160,172 $4.28 Million
Q1 2024 May 14, 2024	SELL	$27.11 - $35.17 $2.3 Million - $2.98 Million	-84,722 Reduced 89.82%	9,603 $327,000
Q4 2023 Feb 13, 2024	BUY	$22.72 - $29.68 $2.14 Million - $2.8 Million	94,325 New	94,325 $2.73 Million
Q2 2023 Aug 14, 2023	BUY	$29.91 - $38.73 $388,590 - $503,180	12,992 Added 28.04%	59,318 $1.78 Million
Q1 2023 May 15, 2023	BUY	$34.93 - $42.03 $494,294 - $594,766	14,151 Added 43.98%	46,326 $1.68 Million
Q4 2022 Feb 14, 2023	BUY	$31.09 - $37.88 $522,498 - $636,611	16,806 Added 109.35%	32,175 $1.15 Million
Q3 2022 Nov 14, 2022	BUY	$28.79 - $35.41 $442,473 - $544,216	15,369 New	15,369 $520,000
Q1 2022 May 09, 2022	SELL	$28.51 - $32.9 $1.48 Million - $1.7 Million	-51,750 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$26.37 - $34.22 $1.36 Million - $1.77 Million	51,750 New	51,750 $1.51 Million
Q3 2020 Nov 12, 2020	SELL	$20.2 - $25.05 $211,574 - $262,373	-10,474 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$17.09 - $24.89 $3,845 - $5,600	-225 Reduced 2.1%	10,474 $249,000
Q1 2020 May 15, 2020	SELL	$14.45 - $24.69 $354,935 - $606,460	-24,563 Reduced 69.66%	10,699 $192,000
Q4 2019 Feb 13, 2020	BUY	$19.93 - $29.13 $702,771 - $1.03 Million	35,262 New	35,262 $836,000

Others Institutions Holding SUPN

# of Institutions

311

Shares Held

61.6M

Call Options Held

11.4K

Put Options Held

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.21B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Supernus Pharmaceuticals, Inc. Transaction History